Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calidi Biotherapeutics, Inc. has filed 406 SEC EDGAR filings since 17 May 2021

SEC filing history

Showing 201-225 of 406 matching filings.

Per page
25
Current page
9
CORRESP

CORRESP filing

Filing date
10 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-276741

S-1/A filing

Filing date
08 Apr 2024
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-276741

S-1/A filing

Filing date
02 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-276741

S-1/A filing

Filing date
01 Apr 2024
Reporting date
Not listed
Next action
Verify source filing
D File 021-508167

D filing

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-508166

D filing

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-508162

D filing

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-508161

D filing

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-508160

D filing

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40789

10-K filing

Filing date
15 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
3

3 filing

Filing date
12 Mar 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-274885

424B3 filing

Filing date
12 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-274885

424B3 filing

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92875

683 CAPITAL MANAGEMENT, LLC

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92875

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92875

SC 13G/A filing

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92875

CALIDI BIOTHERAPEUTICS, INC.

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-274885

424B3 filing

Filing date
12 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .